| scholarly article | Q13442814 |
| P356 | DOI | 10.1096/FJ.02-0072COM |
| P8608 | Fatcat ID | release_lvrqoi6e7jdh7ihojmuy7e5w3i |
| P698 | PubMed publication ID | 12374778 |
| P5875 | ResearchGate publication ID | 11084816 |
| P2093 | author name string | Andre Terzic | |
| Denice M Hodgson | |||
| Leonid V Zingman | |||
| Atta Behfar | |||
| Michel Pucéat | |||
| Garvan C Kane | |||
| Jean-Michel Rauzier | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | stem cell differentiation | Q14864672 |
| P304 | page(s) | 1558-1566 | |
| P577 | publication date | 2002-10-01 | |
| P1433 | published in | FASEB Journal | Q520194 |
| P1476 | title | Stem cell differentiation requires a paracrine pathway in the heart | |
| P478 | volume | 16 |
| Q33659026 | A comparative analysis of extra-embryonic endoderm cell lines |
| Q35161010 | A dual role of the GTPase Rac in cardiac differentiation of stem cells |
| Q45929011 | Adenovirus-mediated hypoxia-inducible factor 1alpha double-mutant promotes differentiation of bone marrow stem cells to cardiomyocytes. |
| Q34477403 | Adhesion proteins, stem cells, and arrhythmogenesis |
| Q35064606 | Akt Increases Sox2 Expression in Adult Hippocampal Neural Progenitor Cells, but Increased Sox2 Does Not Promote Proliferation |
| Q46267096 | An in vitro beating heart model for long-term assessment of experimental therapeutics. |
| Q37420332 | Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy |
| Q40317182 | BMP-2 and FGF-2 synergistically facilitate adoption of a cardiac phenotype in somatic bone marrow c-kit+/Sca-1+ stem cells |
| Q38519839 | Biomaterial Approaches for Stem Cell-Based Myocardial Tissue Engineering |
| Q35808417 | Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells |
| Q42923583 | Bone marrow stromal cells as an inducer for cardiomyocyte differentiation from mouse embryonic stem cells |
| Q42278306 | Calreticulin Is Required for TGF-β-Induced Epithelial-to-Mesenchymal Transition during Cardiogenesis in Mouse Embryonic Stem Cells. |
| Q50537109 | Calreticulin secures calcium-dependent nuclear pore competency required for cardiogenesis. |
| Q33712984 | Can mesenchymal stem cells induce tolerance to cotransplanted human embryonic stem cells? |
| Q37248688 | Carbon nanotube-based substrates promote cardiogenesis in brown adipose-derived stem cells via β1-integrin-dependent TGF-β1 signaling pathway |
| Q42718220 | Cardiac Progenitor Cells and the Interplay with Their Microenvironment |
| Q59938199 | Cardiac Transcription Factors Driven Lineage-Specification of Adult Stem Cells |
| Q37800141 | Cardiac cell therapies: the next generation |
| Q34588417 | Cardiac muscle regeneration: lessons from development |
| Q37253735 | Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease |
| Q36349185 | Cardiac repair by embryonic stem-derived cells |
| Q35897332 | Cardiac specification of embryonic stem cells. |
| Q36267790 | Cardiac stem cells and mechanisms of myocardial regeneration |
| Q37182776 | Cardiac stem cells and progenitors: developmental biology and therapeutic challenges. |
| Q39630514 | Cardiogenesis from human embryonic stem cells |
| Q38167330 | Cardiomyocyte culture - an update on the in vitro cardiovascular model and future challenges. |
| Q53588305 | Cardiomyocyte differentiation induced in cardiac progenitor cells by cardiac fibroblast-conditioned medium. |
| Q36309565 | Cardiomyocytes derived from stem cells |
| Q36289448 | Cardiomyogenesis of embryonic stem cells upon purinergic receptor activation by ADP and ATP. |
| Q37002682 | Cardiomyogenic stem and progenitor cell plasticity and the dissection of cardiopoiesis |
| Q36229704 | Cardiopoietic programming of embryonic stem cells for tumor-free heart repair |
| Q30362960 | Cardioprotective repair through stem cell-based cardiopoiesis. |
| Q30359782 | Cell therapy for cardiac repair--lessons from clinical trials. |
| Q36669952 | Cellular cardiomyoplasty by catheter-based infusion of stem cells in clinical settings |
| Q54387184 | Characterisation and cardiac directed differentiation of canine adult cardiac stem cells. |
| Q35285502 | Chemical compound 31002 stimulates cardiomyogenic differentiation of embryonic stem cells |
| Q28478584 | Combinatorial polymer electrospun matrices promote physiologically-relevant cardiomyogenic stem cell differentiation |
| Q37980722 | Controlling the stem cell compartment and regeneration in vivo: the role of pluripotency pathways |
| Q40442893 | Current status of myocardial regeneration and cell transplantation |
| Q82662246 | Derivation of a cardiopoietic population from human mesenchymal stem cells yields cardiac progeny |
| Q33893826 | Developmental enhancement of adenylate kinase-AMPK metabolic signaling axis supports stem cell cardiac differentiation |
| Q33721600 | Developmental restructuring of the creatine kinase system integrates mitochondrial energetics with stem cell cardiogenesis |
| Q37789112 | Differential gene expressions in atrial and ventricular myocytes: insights into the road of applying embryonic stem cell-derived cardiomyocytes for future therapies |
| Q47575065 | Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats. |
| Q39232292 | Differentiation of reprogrammed mouse cardiac fibroblasts into functional cardiomyocytes. |
| Q36225114 | Differentiation pathways in human embryonic stem cell-derived cardiomyocytes |
| Q30541092 | Direct reprogramming of mouse fibroblasts to cardiomyocyte-like cells using Yamanaka factors on engineered poly(ethylene glycol) (PEG) hydrogels |
| Q36819388 | Discovering small molecules that promote cardiomyocyte generation by modulating Wnt signaling |
| Q36918318 | Do stem cells in the heart truly differentiate into cardiomyocytes? |
| Q36814737 | Donor cell transplantation for myocardial disease: does it complement current pharmacological therapies? |
| Q37766198 | Dynamics of progenitor cells and ventricular assist device intervention |
| Q36404968 | Early cardiac development: a view from stem cells to embryos |
| Q34228118 | Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. |
| Q30505368 | Electron microscopic study of mouse embryonic stem cell-derived cardiomyocytes |
| Q36667292 | Embryonic heart induction |
| Q41853497 | Embryonic stem cell therapy of heart failure in genetic cardiomyopathy |
| Q36862067 | Embryonic stem cell-based cardiopatches improve cardiac function in infarcted rats |
| Q36346482 | Embryonic stem cells and cardiomyocyte differentiation: phenotypic and molecular analyses. |
| Q37992937 | Embryonic stem cells for severe heart failure: why and how? |
| Q37388612 | Embryonic stem cells in cardiac repair and regeneration |
| Q34239856 | Empowering adult stem cells for myocardial regeneration |
| Q37904762 | Engineered approaches to the stem cell microenvironment for cardiac tissue regeneration |
| Q37598911 | Engineering microenvironments for embryonic stem cell differentiation to cardiomyocytes |
| Q36804669 | Engineering stem cells for therapy |
| Q24677311 | Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium |
| Q33842934 | FGF-2 controls the differentiation of resident cardiac precursors into functional cardiomyocytes. |
| Q39633829 | Factors released from embryonic stem cells inhibit apoptosis of H9c2 cells |
| Q37295081 | Fate of undifferentiated mouse embryonic stem cells within the rat heart: role of myocardial infarction and immune suppression |
| Q35221817 | Formation of human myocardium in the rat heart from human embryonic stem cells |
| Q35654315 | Forward Programming of Cardiac Stem Cells by Homogeneous Transduction with MYOCD plus TBX5 |
| Q33771819 | Gender dimorphisms in progenitor and stem cell function in cardiovascular disease |
| Q36675432 | Gene and cell therapy for chronic ischaemic heart disease |
| Q37156670 | Genetic enhancement of stem cell engraftment, survival, and efficacy |
| Q36853977 | Genetic modification of embryonic stem cells with VEGF enhances cell survival and improves cardiac function |
| Q81465001 | Genetic selection of cardiomyocytes from human embryonic stem cells |
| Q36673455 | Genomic chart guiding embryonic stem cell cardiopoiesis |
| Q33724527 | Glycolytic network restructuring integral to the energetics of embryonic stem cell cardiac differentiation |
| Q30496413 | Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction |
| Q36981381 | Guided stem cell cardiopoiesis: discovery and translation |
| Q36606663 | Heart repair and stem cells |
| Q39788971 | High density cultures of embryoid bodies enhanced cardiac differentiation of murine embryonic stem cells |
| Q36025653 | Human embryonic stem cell transplantation to repair the infarcted myocardium |
| Q36804578 | Human embryonic stem cell-derived cardiomyocytes: inducing strategies. |
| Q37023827 | Human embryonic stem cells and cardiac repair |
| Q37262393 | Human embryonic stem cells for cardiomyogenesis |
| Q35184036 | Human embryonic stem cells for myocardial regeneration |
| Q36279078 | Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair. |
| Q28573603 | Identification and functionality of proteomes secreted by rat cardiac stem cells and neonatal cardiomyocytes |
| Q27323532 | Implantation of mouse embryonic stem cell-derived cardiac progenitor cells preserves function of infarcted murine hearts |
| Q40227112 | Improved cardiac function in infarcted mice after treatment with pluripotent embryonic stem cells. |
| Q37812276 | In vivo imaging of embryonic stem cell therapy |
| Q27339181 | In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery |
| Q37349571 | Induced pluripotent reprogramming from promiscuous human stemness related factors. |
| Q39548257 | Induced pluripotent stem (iPS) cells repair and regenerate infarcted myocardium |
| Q38603881 | Induced pluripotent stem cells in cardiovascular medicine |
| Q28116477 | Inhibitory effect of hsa-miR-590-5p on cardiosphere-derived stem cells differentiation through downregulation of TGFB signaling |
| Q33768534 | Initiation of embryonic cardiac pacemaker activity by inositol 1,4,5-trisphosphate-dependent calcium signaling |
| Q37766137 | Interactome of a cardiopoietic precursor |
| Q28508405 | Interplay between the retinoblastoma protein and LEK1 specifies stem cells toward the cardiac lineage |
| Q33586605 | Intramyocardial fibroblast myocyte communication |
| Q33892673 | Intramyocardial transplantation of undifferentiated rat induced pluripotent stem cells causes tumorigenesis in the heart |
| Q36691627 | Isolation and expansion of resident cardiac progenitor cells. |
| Q37240228 | Lineage specification of Flk-1+ progenitors is associated with divergent Sox7 expression in cardiopoiesis. |
| Q83180866 | Long-term modulation of Na+ and K+ channels by TGF-β1 in neonatal rat cardiac myocytes |
| Q38124756 | Mechanistic molecular imaging of cardiac cell therapy for ischemic heart disease |
| Q38210870 | Mesenchymal stem cell insights: prospects in cardiovascular therapy |
| Q37766135 | Mesenchymal stem cells and cardiac repair: principles and practice |
| Q35543468 | MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt pathway in the infarcted heart |
| Q36477618 | Minimally invasive cell-seeded biomaterial systems for injectable/epicardial implantation in ischemic heart disease |
| Q35596393 | Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells |
| Q39635390 | Mitogen‐activated protein kinase in endothelin‐1‐induced cardiac differentiation of mouse embryonic stem cells |
| Q38927381 | Mixl1 and Flk1 Are Key Players of Wnt/TGF-β Signaling During DMSO-Induced Mesodermal Specification in P19 cells |
| Q37898029 | Molecular advances in reporter genes: the need to witness the function of stem cells in failing heart in vivo |
| Q40202347 | Molecular and pharmacological properties of human embryonic stem cell-derived cardiomyocytes |
| Q36883829 | Myoblasts and embryonic stem cells differentially engraft in a mouse model of genetic dilated cardiomyopathy |
| Q37406342 | Myocardial interstitial fluid inhibits proliferation and cardiomyocyte differentiation in pluripotent embryonic stem cells |
| Q36484922 | Myocardial regeneration by embryonic stem cell transplantation: present and future trends |
| Q38045804 | Myocardial regeneration of the failing heart |
| Q33635730 | Myocardial survival signaling in response to stem cell transplantation |
| Q38048838 | New cell therapies in cardiology. |
| Q35596709 | Nitric oxide-cyclic GMP signaling in stem cell differentiation |
| Q38005087 | Optimization of the cardiovascular therapeutic properties of mesenchymal stromal/stem cells-taking the next step. |
| Q79438588 | Optimizing adult mesenchymal stem cells for heart repair |
| Q37606311 | Organotypic heart slices for cell transplantation and physiological studies. |
| Q46705386 | Parietal endoderm secreted SPARC promotes early cardiomyogenesis in vitro |
| Q37885482 | Pharmacologic and genetic strategies to enhance cell therapy for cardiac regeneration |
| Q36900070 | Pharmacoproteomics: advancing the efficacy and safety of regenerative therapeutics |
| Q39266763 | Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy. |
| Q64232878 | PyMINEr Finds Gene and Autocrine-Paracrine Networks from Human Islet scRNA-Seq |
| Q37197074 | Recent advances in cardiovascular regenerative medicine: the induced pluripotent stem cell era. |
| Q35669620 | Recent concepts for the roles of progenitor/stem cell niche in heart repair. |
| Q22251075 | Regenerating the heart |
| Q35749921 | Regenerative capacity of the myocardium: implications for treatment of heart failure |
| Q35005781 | Regulation of PTEN/Akt pathway enhances cardiomyogenesis and attenuates adverse left ventricular remodeling following thymosin β4 Overexpressing embryonic stem cell transplantation in the infarcted heart |
| Q37401842 | Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. |
| Q33509377 | Retinoic acid enhances skeletal muscle progenitor formation and bypasses inhibition by bone morphogenetic protein 4 but not dominant negative beta-catenin. |
| Q37766134 | Review of stem cell-based therapy for the treatment of cardiovascular disease |
| Q37354707 | Rigid microenvironments promote cardiac differentiation of mouse and human embryonic stem cells |
| Q35064180 | Role of nitric oxide signaling in endothelial differentiation of embryonic stem cells |
| Q50511402 | Secreted factors from adipose tissue increase adipogenic differentiation of mesenchymal stem cells. |
| Q37787113 | Signaling pathways in early cardiac development |
| Q39376204 | Single-cell level co-culture platform for intercellular communication |
| Q34292182 | Small molecule-mediated TGF-β type II receptor degradation promotes cardiomyogenesis in embryonic stem cells |
| Q35125820 | Stem Cell Therapy in Acute Myocardial Infarction: A Pot of Gold or Pandora's Box. |
| Q33348580 | Stem cell therapy: pieces of the puzzle |
| Q34315088 | Stem cell treatment of the heart: a review of its current status on the brink of clinical experimentation |
| Q35832759 | Stem cells and repair of the heart. |
| Q37261623 | Stem cells for heart cell therapies |
| Q37766200 | Stem cells in the infarcted heart |
| Q38450046 | Stem cells transform into a cardiac phenotype with remodeling of the nuclear transport machinery |
| Q34325607 | Steps toward safe cell therapy using induced pluripotent stem cells |
| Q36380582 | Strategies for developing therapeutic application of human embryonic stem cells. |
| Q37968752 | Strategies for replacing myocytes with induced pluripotent stem in clinical protocols |
| Q43071534 | TGF-beta1 enhances cardiomyogenic differentiation of skeletal muscle-derived adult primitive cells |
| Q33652407 | TGF-β1 induces senescence of bone marrow mesenchymal stem cells via increase of mitochondrial ROS production |
| Q37701775 | The current status of engineering myocardial tissue |
| Q34576247 | The long-term differentiation of embryonic stem cells into cardiomyocytes: an indirect co-culture model |
| Q36655326 | The role of TGF-beta signaling in myocardial infarction and cardiac remodeling |
| Q35661004 | The role of stem cells for treatment of cardiovascular disease |
| Q39265526 | The role of transforming growth factor (TGF)-β in the infarcted myocardium |
| Q38007911 | The voyage of stem cell toward terminal differentiation: a brief overview |
| Q54358091 | Three-dimensional co-culture facilitates the differentiation of embryonic stem cells into mature cardiomyocytes. |
| Q39162692 | Time-dependent regulation of neuregulin-1β/ErbB/ERK pathways in cardiac differentiation of mouse embryonic stem cells |
| Q38322176 | Tissue engineering approaches to heart repair |
| Q40334464 | Transcriptional profiling of reporter genes used for molecular imaging of embryonic stem cell transplantation |
| Q24302152 | Transforming growth factor-beta2 enhances differentiation of cardiac myocytes from embryonic stem cells |
| Q81708992 | Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells |
| Q81228975 | Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study |
| Q40148211 | Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling. |
| Q33683767 | Unchain my heart: the scientific foundations of cardiac repair |
| Q37448571 | iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism |
| Q36246408 | miR-300 mediates Bmi1 function and regulates differentiation in primitive cardiac progenitors. |
Search more.